The SECURE Study Team, are inviting people diagnosed with Monoclonal gammopathy of unknown significance (Monoclonal gammopathy of unknown significance (MGUS)) or their family members/carers to join a Patient and Public Involvement (PPI) group.
No medical or research background is needed, and you can take part from anywhere in the UK.
What’s Involved?
-
Join online meetings (around 1 hour each) -
Complete a short questionnaire to share your views
-
Give feedback on the study design
This group will help shape a new study exploring whether GLP-1 medications (commonly used for weight loss) could improve metabolic health in people with Monoclonal gammopathy of unknown significance (Monoclonal gammopathy of unknown significance (MGUS)).
Interested?
Email: secure@oxnet.nhs.uk to sign up or learn more.
Want to learn more about the SECURE Study?
SECURE is a UK-wide observational research study currently open to recruitment. It aims to improve the understanding of Monoclonal gammopathy of unknown significance (Monoclonal gammopathy of unknown significance (MGUS)).
Who Can Take Part?
- Anyone with a confirmed or suspected case of Monoclonal gammopathy of unknown significance (Monoclonal gammopathy of unknown significance (MGUS))
Want to learn more: Click here (Study Details | NCT05539079 | A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance | ClinicalTrials.gov)